Edge Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Edge Capital Group's LLY Position: Q4 2024 in Review
Edge Capital Group reduced its Eli Lilly (LLY) stake by 12% in Q4 2024, selling an estimated $1.19M and leaving 10,509 shares worth $8.11M. The position accounts for 0.36% of the portfolio, ranked #61.
Edge Capital Group first reported a position in LLY in Q3 2020 and has held it in 18 quarters since. The position peaked at $12.2M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Edge Capital Group held 10,509 shares of Eli Lilly worth $8.11M as of Q4 2024.
- Edge Capital Group sold 1,435 Eli Lilly shares in Q4 2024, an estimated $1.19M.
- Eli Lilly made up 0.36% of Edge Capital Group's portfolio in Q4 2024, its #61 holding.
- Edge Capital Group first reported a position in Eli Lilly in Q3 2020 and has held it in 18 quarters since.
- Edge Capital Group's Eli Lilly position peaked at $12.2M in Q2 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.